Product/Composition:- | Tranexamic Acid |
---|---|
Strength:- | Oral Tablets: 250 mg, 500 mg, 650 mg & (IV) Injection::100 mg/mL |
Form:- | Oral & Injectable |
Reference Brands:- | Lysteda, Cyklokapron®, Transamin®, |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Tranexamic Acid is an antifibrinolytic agent used to prevent and treat excessive bleeding, available in oral and injectable forms for B2B pharma distribution in the US and EU.
Tranexamic Acid is a widely used antifibrinolytic agent available for B2B pharmaceutical supply across the US and EU. Indicated for the treatment and prevention of excessive bleeding, including heavy menstrual bleeding, surgical hemorrhage, and trauma-related blood loss, Tranexamic Acid helps stabilize clots by inhibiting plasminogen activation. Offered in both oral (500 mg tablets) and injectable (100 mg/mL) forms, it is ideal for hospitals, clinics, and gynecology practices. Regulatory-compliant and GMP-certified, Tranexamic Acid ensures high demand across markets focused on bleeding control and pre-operative care. B2B partners benefit from reliable sourcing and strong market demand in both acute and chronic care settings.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications